The effects of PI3K-AKT signalling pathways, which are independent of those of CTLA-4, may indicate that combined CTLA-4 and VISTA blockade in HNSCC may be more effective than combined PD-1 and VISTA blockade [25,28]. This evidence concerns the gene CTLA4 and head and neck squamous cell carcinoma.